When attendees of the European Respiratory Society (ERS) meeting, held in Stockholm in September 2007, were presented with the Asmair® pMDI prototype inhaler from Bang & Olufsen Medicom, they gave the company “positive feedback,” according to the latest press release by B&O. We have not seen this gadget, but for what this “positive feedback” is worth, we think the response was such due to the promises for the device to sport many interesting and helpful features, not found on any inhalers nowadays:
The device prevents undercounting – a single dose counter is designed to specifically avoid under-counting – helping patients understand their treatment regimes.
The device also helps prevent overcounting – helping patients remain in control of their dosage. With the counter monitoring exact dosing, the patient can now for the first time rely directly on the dose counter to see how much medication or dosage remains.
Another key feature is that there is 50% less force required to release a dose when compared with normal inhaler- easy-to-use design for the elderly and children.
Optional reusable cap
The reusable cap reminds patients to take their dose and gives feedback to the patient on actual compliance level (via a visual signal)